title: New target therapies for patients with neuroendocrine tumors of the pancreas.
authors.forename: Georgios
authors.initials: G
authors.lastname: Baltogiannis
authors.forename: Christos
authors.initials: C
authors.lastname: Katsios
authors.forename: Dimitrios H
authors.initials: DH
authors.lastname: Roukos
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000068338:Everolimus; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011758:Pyrroles / Q000627:therapeutic use*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077210:Sunitinib; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000068338:Everolimus; D000077210:Sunitinib; D020123:Sirolimus